Remove 2004 Remove FDA Remove Process Improvement
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

September 2004. Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice.” September 2004. Aseptic Processing: A Vision of the Future.” Product Focus: Advancing Aseptic Processing.” FDA Official Warns Manufacturers of Common Problems Found in Aseptic Operations.” 12 July 2019.

article thumbnail

Regulatory Landscape for Raw Materials: CMC Considerations

ISPE

In addition, single-use technologies have been increasingly employed throughout manufacturing because of the advantages they offer, including reductions in cost, manufacturing footprint, contamination risk, and processing times (Figure 1). There is undoubtedly a need for improved supply chain flexibility to address shortages.